Current role
Biotechnology · Healthcare
CEO, Board Member
2023-01-01–present
George Ng
Equibles does not estimate personal net worth.
Get an email with a short summary when Processa Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get PCSA alertsAbout George Ng
George Ng is recorded as Board Member at Processa Pharmaceuticals, Inc. (PCSA) since January 1, 2023 and CEO at Processa Pharmaceuticals, Inc. (PCSA). The newest filing on record that lists George Ng as CEO and Board Member at Processa Pharmaceuticals, Inc. (PCSA) is dated June 18, 2026. Processa Pharmaceuticals, Inc. reported in an 8-K filed August 8, 2023 that George Ng was appointed director, effective August 8, 2023. Processa Pharmaceuticals, Inc. reported in an 8-K filed August 8, 2023 that George Ng was appointed Chief Executive Officer, effective August 8, 2023. The proxy statement of Processa Pharmaceuticals, Inc. reports total compensation of $673,303 for George Ng in fiscal 2025, including a base salary of $400,000. Disclosed compensation is on record for 4 fiscal years. Processa Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Processa Pharmaceuticals, Inc. includes Russell L. Skibsted (CFO), Russell Skibsted (CFO), David Young (Board Member) and 7 others.
“On August 8, 2023, Processa Pharmaceuticals, Inc. (the "Company") announced the appointment of Mr. George Ng as its Chief Executive Officer and a director.”
“On August 8, 2023, Processa Pharmaceuticals, Inc. (the "Company") announced the appointment of Mr. George Ng as its Chief Executive Officer and a director.”
Affiliation history
-
Current
2023-01-01–present
Last confirmed June 18, 2026
-
Current
Start not stated–present
Last confirmed June 18, 2026
Company network
Leadership on record at Processa Pharmaceuticals, Inc.
- Russell L. Skibsted CFO
- Russell Skibsted CFO
- David Young Board Member
- Geraldine Pannu Board Member
- James Neal Board Member
- James R. Neal Board Member
- Justin Yorke Board Member
- Khoso Baluch Board Member
- Sheila Gujrathi Board Member
- Virgil Thompson Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Executive Officer | $400,000 | $673,303 |
| 2024 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Executive Officer | $400,000 | $521,033 |
| 2023 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Executive Officer | $159,091 | $471,091 |
| 2022 | Processa Pharmaceuticals, Inc. (PCSA) | Chief Executive Officer | — | — |